Skip to main content
Karo Pharma AB logo

Karo Pharma AB — Investor Relations & Filings

Ticker · KARO ISIN · SE0007464888 LEI · 213800G54Z51LOPGTA79 ST Manufacturing
Open in API
Filings indexed 653 across all filing types
Latest filing 2015-04-23 AGM Information
Country SE Sweden
Listing ST KARO

About Karo Pharma AB

https://www.karohealthcare.com/

Karo Pharma AB, operating as Karo Healthcare, is a healthcare company that develops, markets, and sells a broad portfolio of everyday healthcare products. The company's offerings are designed to prevent illness and treat common health problems, empowering consumers to manage their daily well-being. The portfolio consists of various branded medicines and consumer healthcare products distributed through pharmacies and directly to healthcare providers. With products available in over 90 countries, the company focuses on becoming a leading force in its sector by employing a consumer-centric approach, strategic innovation, and omnichannel excellence.

Recent filings

Filing Released Lang Actions
THE NOMINATION COMMITTEE’S PROPOSALS TO THE ANNUAL GENERAL MEETING IN KARO BIO AB (PUBL)
AGM Information Classification · 98% confidence The document is explicitly titled 'THE NOMINATION COMMITTEE'S PROPOSALS TO THE ANNUAL GENERAL MEETING IN KARO BIO AB (PUBL)' and details the committee's recommendations for board members and auditor re-elections/appointments ahead of the 2015 AGM. This content directly relates to the agenda and proposals presented for the Annual General Meeting. Therefore, the most appropriate classification is AGM Information (AGM-R). The document length (2666 chars) is short, but it contains the substantive proposals, not just an announcement that proposals exist, making AGM-R more specific than RPA or RNS.
2015-04-23 English
KARO BIO FÖRVÄRVAR FÖRKYLNINGSPRODUKT
M&A Activity Classification · 98% confidence The document is a short press release dated April 10, 2015, announcing that Karo Bio has signed an agreement to acquire Tanomed AB and its cold remedy product. This describes a corporate action related to mergers, acquisitions, or significant asset purchases. Based on the definitions, this falls under 'M&A Activity' (Code: TAR). It is not a full financial report (10-K, IR), an earnings release (ER), or a general regulatory filing (RNS), as it specifically details a takeover/acquisition proposal.
2015-04-10 Swedish
KARO BIO ACQUIRES PRODUCT FOR TREATMENT OF COMMON COLD
Regulatory Filings Classification · 99% confidence The document text is a press release announcing a specific corporate action: the acquisition of Tanomed AB for a drug research product. This type of announcement, detailing a merger or takeover proposal, directly aligns with the definition of M&A Activity (TAR). It is not a standard regulatory filing like 10-K or IR, nor is it a general earnings release (ER) or a report publication announcement (RPA), as it contains the substance of the transaction itself. The document mentions the financing method ('through a share issue'), but the core event is the acquisition.
2015-04-10 English
Annual Report 2015
Annual Report Classification · 100% confidence The document is a comprehensive annual report for Karo Bio AB for the fiscal year 2014. It contains a table of contents, management reports, financial statements (income statement, balance sheet, cash flow), notes, and an audit report. It is clearly the full annual report, not an announcement or a summary. FY 2015
2015-04-08 Swedish
Annual Report 2014
Annual Report Classification · 100% confidence The document is clearly identified as the 'Karo Bio annual report 2014' based on the title page content, the inclusion of a five-year financial overview, consolidated income statements, balance sheets, cash flow statements, audit report, and corporate governance report. It covers the full fiscal year 2014 and provides comprehensive financial and operational performance data, fitting the definition of an Annual Report (10-K). FY 2014
2015-04-08 English
KALLELSE TILL ÅRSSTÄMMA I KARO BIO AB (publ)
AGM Information Classification · 100% confidence The document is explicitly titled "KALLELSE TILL ÅRSSTÄMMA I KARO BIO AB (publ)" which translates to "NOTICE OF ANNUAL GENERAL MEETING IN KARO BIO AB (publ)". It details the date, time, location, requirements for participation, the proposed agenda (including election of directors, approval of financial statements, and remuneration guidelines), and information about available documents for the meeting. This content perfectly matches the definition of materials shared for an Annual General Meeting (AGM). Therefore, the correct classification is AGM-R.
2015-03-30 Swedish

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.